Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

3 articles from the last 30 days matching "pathophysiology"

NewsRSSMay 12

Test Your Knowledge About the Pathophysiology of CHAPLE Disease

This article invites people to take a quiz about how CHAPLE disease works in the body and see how their knowledge compares to other people who took the same quiz. CHAPLE is a rare genetic disease, and understanding how it develops and affects the body is important for patients and caregivers. The quiz helps test what you know about the disease's mechanisms.

WHY IT MATTERSFor CHAPLE disease patients and caregivers, understanding the disease's underlying biology can help you have more informed conversations with your doctor and better understand your diagnosis and treatment options.
ℹ Good to knowCHAPLE disease
ResearchRSSMay 12

ALS Pathophysiology

Scientists are still trying to understand exactly what causes ALS (a disease that weakens muscles over time). Researchers have identified many different problems that happen in the brains of people with ALS—like too much of a chemical called glutamate, broken energy-producing parts of cells, and inflammation—but they don't yet know which problem starts the disease or in what order these problems happen.

WHY IT MATTERSUnderstanding what actually triggers ALS is essential for developing treatments that address the root cause rather than just the symptoms, which could eventually lead to better ways to slow or stop the disease.
ℹ Good to know
GrantNIH REPORTERMay 11

New NIH Grant: Tools and Resources to Understand Pathophysiology with Post-Mortem Studies of in vivo Neuroimaging F — $20K at Unknown Institution

Researchers are receiving funding to study how brain imaging scans taken while people are alive compare to what they find when examining brain tissue after death. This work focuses on Alzheimer's disease and related memory disorders, and aims to confirm whether the imaging scans are accurately detecting the brain changes that cause these diseases.

WHY IT MATTERSThis research will help doctors develop better brain imaging tests that can catch Alzheimer's disease and related dementias earlier, potentially before symptoms become severe.
ℹ Good to knowAlzheimer's diseaseAlzheimer's disease-related dementias

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases